Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novartis files supplemental NDA for Starlix

Jan. 3, 2003

Isis Pharmaceuticals reacquires ISIS-113715 from Merck

Jan. 2, 2003

Taisho presents arginine-based MC4 receptor ligands

Jan. 2, 2003

E.U. approval obtained for once-weekly Actonel/Optinate for postmenopausal osteoporosis

Jan. 2, 2003

Acologix begins phase I trial of dentonin

Jan. 2, 2003

GSK identifies new series of human PPAR agonists and potential uses

Dec. 30, 2002

Positive opinion in E.U. for Lilly's teriparatide in established osteoporosis

Dec. 30, 2002

Biovitrum presents novel 5-HT6 antagonists for obesity, diabetes and CNS disorders

Dec. 30, 2002

Novel PPARalpha/gamma receptor agonists in early development at Roche

Dec. 30, 2002

Positive results for AC-2993 open-label study in type 2 diabetes

Dec. 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...